Apellis is a global biopharmaceutical company that leverages courageous science, creativity, and compassion to develop life-changing therapies.
Leaders in Complement, at the forefront of targeted C3 therapies, we aim to develop transformative therapies for debilitating diseases driven by excessive activation of the complement cascade, including hematology, ophthalmology, nephrology, and neurology.
For all general inquiries, please contact email@example.com
For all medical inquiries, please contact firstname.lastname@example.org
Important External Links: